Date |
Time |
Source |
Heading |
5/24/2024 | 16:33 | EDGAR2 | Form 8-K - Current report |
5/24/2024 | 10:19 | EDGAR2 | Form 8-K - Current report |
5/24/2024 | 09:20 | GLOBE | Renovaro Inc. and Amsterdam UMC Cancer Center Poised to.. |
5/17/2024 | 21:37 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
4/30/2024 | 11:00 | GLOBE | Transforming Cancer Detection: RenovaroCube Introduces.. |
4/24/2024 | 09:00 | GLOBE | RenovaroCube to Acquire 100% Ownership of Cyclomics,.. |
4/18/2024 | 08:45 | GLOBE | Renovaro Inc. Proudly Announces the Appointment Of Professor.. |
3/07/2024 | 17:00 | EDGAR2 | Form 8-K - Current report |
3/05/2024 | 17:03 | EDGAR2 | Form 8-K - Current report |
2/28/2024 | 15:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/23/2024 | 17:01 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
2/22/2024 | 16:35 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/22/2024 | 16:17 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2/20/2024 | 16:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2/15/2024 | 09:25 | GLOBE | Cutting Edge AI Company GEDiCube and Cyclomics sign binding.. |
2/14/2024 | 10:01 | GLOBE | Statement of Renovaro Inc |
2/13/2024 | 09:46 | GLOBE | Cutting Edge AI Company GEDiCube and Cyclomics sign binding.. |
2/13/2024 | 09:31 | GLOBE | AI Pioneer GEDi Cube and Biotech Innovator Renovaro.. |
1/25/2024 | 12:45 | GLOBE | Renovaro Biosciences Announces Results of Special Meeting of.. |
1/16/2024 | 08:00 | GLOBE | Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark.. |
10/11/2023 | 09:25 | GLOBE | Avram Miller, Co-Founder of Intel Capital, Joins Renovaro.. |
10/10/2023 | 08:00 | GLOBE | Renovaro Biosciences Appoints Two Finance Industry Experts.. |
10/06/2023 | 16:34 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
10/06/2023 | 16:30 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
10/04/2023 | 16:20 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
10/04/2023 | 16:15 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
10/02/2023 | 12:05 | GLOBE | Message from Renovaro Biosciences CEO, The Hon. Mark Dybul,.. |
10/02/2023 | 09:28 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
10/02/2023 | 09:26 | EDGAR2 | Form 8-K - Current report |
10/02/2023 | 09:25 | GLOBE | AI Company GEDiCube and Renovaro Biosciences Sign Definitive.. |
10/02/2023 | 07:30 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
9/30/2023 | 03:32 | BW | GEDi Cube und Renovaro Biosciences unterzeichnen endgültige.. |
9/29/2023 | 17:26 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
9/29/2023 | 17:24 | EDGAR2 | Form 8-K - Current report |
9/29/2023 | 17:00 | EDGAR2 | Form NT 10-K - Notification of inability to timely file Form.. |
9/29/2023 | 13:36 | BW | GEDi Cube et Renovaro Biosciences signent un accord.. |
9/29/2023 | 09:15 | GLOBE | Renovaro Biosciences and AI Health Company GEDi Cube Sign.. |
9/12/2023 | 06:08 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/30/2023 | 09:15 | GLOBE | Renovaro BioSciences Welcomes GEDiCube Announcement of New.. |
8/21/2023 | 09:15 | GLOBE | Renovaro BioSciences Congratulates GEDi Cube on Appointment.. |
8/09/2023 | 09:05 | EDGAR2 | Form 8-K - Current report |
8/09/2023 | 09:00 | GLOBE | AI Company GEDi Cube and Renovaro Biosciences Announce a.. |